Potential Use of Janus Kinase Inhibitors in the Treatment of Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is a chronic, autoimmune disease with unclear pathogenesis. One characteristic of SLE is pro-inflammatory and anti-inflammatory cytokine imbalance. Janus kinase (JAK) is an intracellular non-receptor tyrosine kinase essential for many cytokine signaling pathways. D...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Rongxiu, Huang, Xinxiang, Yang, Yang, Lin, Jinying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084827/
https://www.ncbi.nlm.nih.gov/pubmed/37051062
http://dx.doi.org/10.2147/JIR.S397639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084827/
https://www.ncbi.nlm.nih.gov/pubmed/37051062
http://dx.doi.org/10.2147/JIR.S397639

Ejemplares similares